Literature DB >> 27617152

Von Hippel-Lindau Disease.

Jennifer J Findeis-Hosey1, Kelly Q McMahon2, Sarah K Findeis3.   

Abstract

Von Hippel-Lindau disease is an autosomal dominant syndrome which occurs secondary to germline mutations in the VHL tumor suppressor gene, located on chromosome 3. Clinically von Hippel-Lindau disease is characterized by an increased risk of developing simple visceral cysts, most commonly in the pancreas and kidneys, in addition to an increased risk of developing neoplasms, often with clear cell features, in a multitude of organ systems. The most common neoplasms are cerebellar and retinal hemangioblastomas, adrenal pheochromocytomas, clear cell renal cell carcinomas, pancreatic neuroendocrine tumors, pancreatic serous cystadenomas, and endolymphatic sac tumors. These lesions most commonly present during adulthood; however, screening and surveillance for the development of these lesions should begin in the pediatric years for patients with von Hippel-Lindau disease. In this review article, the genetics and most common neoplasms of von Hippel-Lindau disease are reviewed, with an eye towards implications for the pediatric patient.

Entities:  

Keywords:  pathology; pediatric; von Hippel–Lindau

Year:  2016        PMID: 27617152      PMCID: PMC4918695          DOI: 10.1055/s-0036-1579757

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  77 in total

Review 1.  Review and hypotheses: somatic mosaicism: observations related to clinical genetics.

Authors:  J G Hall
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

2.  Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment.

Authors:  Jennifer F Tseng; Andrew L Warshaw; Dushyant V Sahani; Gregory Y Lauwers; David W Rattner; Carlos Fernandez-del Castillo
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

3.  Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL.

Authors:  E R Woodward; C Eng; R McMahon; R Voutilainen; N A Affara; B A Ponder; E R Maher
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

4.  Recurrence risk for germinal mosaics revisited.

Authors:  M A van der Meulen; M J van der Meulen; G J te Meerman
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

5.  Renal lesions in von Hippel-Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins.

Authors:  F Paraf; D Chauveau; Y Chrétien; S Richard; J P Grünfeld; D Droz
Journal:  Histopathology       Date:  2000-05       Impact factor: 5.087

Review 6.  Molecular basis of the VHL hereditary cancer syndrome.

Authors:  William G Kaelin
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

7.  Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment.

Authors:  Joon Ho Na; Hyeong Soo Kim; Whan Eoh; Jong Hyun Kim; Jong Soo Kim; Eun-Sang Kim
Journal:  J Korean Neurosurg Soc       Date:  2007-12-20

8.  Retinal capillary hemangiomas: clinical manifestations and visual prognosis.

Authors:  Ming-Tse Kuo; Hsi-Kung Kou; Min-Lun Kao; Ming-Hsiung Tsai; Yung-Jen Chen; Sue-Ann Lin
Journal:  Chang Gung Med J       Date:  2002-10

9.  Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.

Authors:  E R Maher; A R Webster; F M Richards; J S Green; P A Crossey; S J Payne; A T Moore
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

10.  Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.

Authors:  Lauren Fishbein; Shana Merrill; Douglas L Fraker; Debbie L Cohen; Katherine L Nathanson
Journal:  Ann Surg Oncol       Date:  2013-03-20       Impact factor: 5.344

View more
  10 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

2.  The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass.

Authors:  David Malkin; Kim E Nichols; Joshua D Schiffman; Sharon E Plon; Garrett M Brodeur
Journal:  Clin Cancer Res       Date:  2017-11-01       Impact factor: 12.531

3.  Von Hippel-Lindau disease with extramedullary and pancreatic involvement.

Authors:  Andrea Pantigozo-Rimachi; Giuliana Murillo-Díaz; Nilton Yhuri Carreazo; Victor Manuel Cucho Dávila
Journal:  Med J Armed Forces India       Date:  2020-05-07

4.  Increased prevalence of renal cysts in patients with sickle cell disease.

Authors:  Daveena Meeks; Arunraj Navaratnarajah; Emma Drasar; Ounali Jaffer; C Jason Wilkins; Swee Lay Thein; Claire C Sharpe
Journal:  BMC Nephrol       Date:  2017-09-21       Impact factor: 2.388

Review 5.  When should genetic testing be performed in patients with neuroendocrine tumours?

Authors:  Triona O'Shea; Maralyn Druce
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 6.  Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis.

Authors:  Dmitry S Mikhaylenko; Alexander S Tanas; Dmitry V Zaletaev; Marina V Nemtsova
Journal:  J Oncol       Date:  2020-06-17       Impact factor: 4.375

7.  Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial.

Authors:  Beatriz González-Rodríguez; Karina Villar Gómez de Las Heras; Daniel T Aguirre; Luis Rodríguez-Padial; Virginia Albiñana; Lucía Recio-Poveda; Angel M Cuesta; Luisa Mª Botella; Rosa María Jiménez-Escribano
Journal:  BMJ Open Ophthalmol       Date:  2019-05-28

Review 8.  The Genetic Basis of Strokes in Pediatric Populations and Insight into New Therapeutic Options.

Authors:  Milena Jankovic; Bojana Petrovic; Ivana Novakovic; Slavko Brankovic; Natasa Radosavljevic; Dejan Nikolic
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

9.  Radiologic screening and surveillance in hereditary cancers.

Authors:  Jamie E Clarke; Stephanie Magoon; Irman Forghani; Francesco Alessandrino; Gina D'Amato; Emily Jonczak; Ty K Subhawong
Journal:  Eur J Radiol Open       Date:  2022-04-25

10.  Clinical and Laboratory Characteristics of a Large Iranian Kindred Afflicted with Von Hippel Lindau Disease.

Authors:  Ali Asghar Mir Saeid Ghazi; Atieh Amouzegar; Azita Zadeh-Vakili; Abdolreza Sheikh Rezaei; Alireza Amirbaigloo; Marjan Zarif Yeganeh; Hasan Hashemi; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2021-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.